Terasu相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Effect of Partial Splenic Embolization on Immune Environment and Hepatic Function in Cirrhosis Patients With Portal Hypertension

部分脾栓塞对门静脉高压性肝硬化患者免疫环境和肝功能的影响

影响因子:1.8

doi:10.21873/invivo.14201

Ishikawa, Toru; Sato, Ryo; Natsui, Hiroki; Iwasawa, Takahiro; Ogawa, Masahiro; Kobayashi, Yuji; Sato, Toshifumi; Yokoyama, Junji; Honma, Terasu

免疫/内分泌

发表日期：2026

文献求助收藏

Partial Splenic Embolization for Portal Hypertension Exacerbation During Atezolizumab/Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma

不可切除肝细胞癌患者接受阿特珠单抗/贝伐珠单抗联合治疗期间出现门静脉高压加重时行脾部分栓塞术

影响因子:1.8

doi:10.21873/invivo.13898

Ishikawa, Toru; Terai, Nanako; Sato, Ryo; Natsui, Hiroki; Iwasawa, Takahiro; Ogawa, Masahiro; Kobayashi, Yuji; Sato, Toshifumi; Yokoyama, Junji; Iiduka, Akihiko; Honma, Terasu

细胞生物学

发表日期：2025

文献求助收藏

Transjugular Liver Biopsy for Histological Diagnosis of Refractory Ascites and Evaluation of Portal Hypertension

经颈静脉肝活检用于难治性腹水的组织学诊断和门静脉高压的评估

影响因子:1.8

doi:10.21873/invivo.13959

Ishikawa, Toru; Sato, Ryo; Natsui, Hiroki; Iwasawa, Takahiro; Ogawa, Masahiro; Kobayashi, Yuji; Sato, Toshifumi; Yokoyama, Junji; Honma, Terasu

发表日期：2025

文献求助收藏

Preoperative Visitation Effect on Quality of Life of Patients Undergoing Transarterial Chemoembolization for Hepatocellular Carcinoma

术前探视对接受经动脉化疗栓塞治疗肝细胞癌患者生活质量的影响

doi:10.21873/cdp.10434

Ishikawa, Toru; Suzuki, Atsuko; Yamamoto, Hiromi; Arita, Narumi; Matsuhashi, Yusuke; Kobayashi, Nao; Nakagawa, Eriko; Terai, Nanako; Hoshii, Asami; Honma, Terasu

细胞生物学

发表日期：2025

文献求助收藏

Angiotensin Receptor Neprilysin Inhibitors for Hypertension and Proteinuria Management During Atezolizumab/Bevacizumab Treatment for Hepatocellular Carcinoma

在接受阿特珠单抗/贝伐珠单抗治疗肝细胞癌期间，使用血管紧张素受体脑啡肽酶抑制剂控制高血压和蛋白尿

doi:10.21873/cdp.10462

Ishikawa, Toru; Sato, Ryo; Natsui, Hiroki; Iwasawa, Takahiro; Ogawa, Masahiro; Kobayashi, Yuji; Sato, Toshifumi; Yokoyama, Junji; Honma, Terasu

细胞生物学

发表日期：2025

文献求助收藏

Efficacy of Durvalumab-Tremelimumab Treatment in Combination With Locoregional Therapy in Unresectable Hepatocellular Carcinoma: A Preliminary Study

Durvalumab-Tremelimumab联合局部区域治疗不可切除肝细胞癌的疗效：一项初步研究

doi:10.21873/cdp.10473

Ishikawa, Toru; Sato, Ryo; Natsui, Hiroki; Iwasawa, Takahiro; Ogawa, Masahiro; Kobayashi, Yuji; Sato, Toshifumi; Yokoyama, Junji; Honma, Terasu

细胞生物学

发表日期：2025

文献求助收藏

Complete suspension culture of human induced pluripotent stem cells supplemented with suppressors of spontaneous differentiation

补充有自发分化抑制剂的人类诱导性多能干细胞的完全悬浮培养

影响因子:6.4

doi:10.7554/eLife.89724

Mami Matsuo-Takasaki, Sho Kambayashi, Yasuko Hemmi, Tamami Wakabayashi, Tomoya Shimizu, Yuri An, Hidenori Ito, Kazuhiro Takeuchi, Masato Ibuki, Terasu Kawashima, Rio Masayasu, Manami Suzuki, Yoshikazu Kawai, Masafumi Umekage, Tomoaki M Kato, Michiya Noguchi, Koji Nakade, Yukio Nakamura, Tomoyuki Nak

发育与干细胞

发表日期：2024

文献求助收藏

Determinants of Survival of Ablation Treatment for Portal Vein Tumor Thrombus in Patients With Hepatocellular Carcinoma

影响肝细胞癌患者门静脉肿瘤血栓消融治疗生存率的因素

影响因子:1.8

doi:10.21873/invivo.13721

Ishikawa, Toru; Sato, Ryo; Jimbo, Ryo; Kobayashi, Yuji; Sato, Toshifumi; Iwanaga, Akito; Sano, Tomoe; Yokoyama, Junji; Honma, Terasu

细胞生物学

发表日期：2024

文献求助收藏

Relationship Between Sleep Quality and Quality of Life: Analysis of Hepatocellular Carcinoma Survivors

睡眠质量与生活质量的关系：肝细胞癌幸存者的分析

期刊:Cureus Journal of Medical Science

影响因子:1.3

doi:10.7759/cureus.63883

Ishikawa, Toru; Arita, Narumi; Matsuhashi, Yusuke; Honma, Terasu

细胞生物学

发表日期：2024

文献求助收藏

Comparison of Local Recurrence Between LEN-TACE and TACE for Hepatocellular Carcinoma According to Lipiodol Accumulation

根据碘油积聚情况比较 LEN-TACE 与 TACE 治疗肝细胞癌的局部复发率

doi:10.21873/cdp.10371

Ishikawa, Toru; Sato, Ryo; Jimbo, Ryo; Kobayashi, Yuji; Sato, Toshifumi; Iwanaga, Akito; Sano, Tomoe; Yokoyama, Junji; Honma, Terasu

细胞生物学

发表日期：2024

文献求助收藏